Inhalation Sample Clauses

Inhalation. Two concentrations of each test substance shall be used in this portion of the study, a low con- centration and a high concentration. The high concentration should induce minimal toxicity, but shall not exceed the lower explosive limit (LEL). The low concentration shall correspond to 1/10 of the high concentration. Inhala- tion treatment shall be conducted using a ‘‘nose-cone’’ or ‘‘head only’’ ap- paratus to reduce ingestion of the test substance through ‘‘grooming’’ or der- mal absorption.

Inhalation. T wo co n ce n t r a t io n s of e a c h t es t s u bs t a n ce s h a ll be u sed i n t h i s po r t io n of t h e s t u d y , a low co n- ce n t r a t io n a n d a h ig h co n ce n t r a t io n . T h e h ig h co n ce n t r a t io n s h o u ld i n d u ce m i n i m a l t oxici t y , b u t s h a ll n o t exceed t h e lowe r explosive li m i t ( LEL). T h e low co n ce n t r a t io n s h a ll co rr espo n d t o 1/10 of t h e h ig h co n ce n t r a t io n . I nh a l a- t io n t r e a t m e n t s h a ll be co n d u c t ed u s i n g a ‘‘n ose- co n e’’ o r ‘‘h e a d o n l y’’ a p- p a r a t u s t o r ed u ce i n ges t io n of t h e t es t s u bs t a n ce t hr o u g h ‘‘g r oo m i n g’’ o r de r - m a l a bso r p t io n .

Inhalation. May cause irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. Ingestion: May cause irritation to the gastrointestinal tract, nausea, vomiting and abdominal pain. Symptoms may include headaches, blurred vision, fatigue, drowsiness and nervous system depression. CHRONIC: Repeated or prolonged exposure may cause skin rash and irritation of mucous membranes. Repeated ingestion may cause central nervous system deer ion, irritability and headache. Medical Conditions Aggravated by Exposure: Persons suffering from depression, alcoholism, neurological or psychological disorders may be more susceptible to the effects of the substance. 11F PA Rating: Health = 2: Flammability = 0: Instability = 0 (Rating is for dry material, no information on blended solution).

Inhalation. May cause irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. Ingestion: May cause irritation to the gastrointestinal tract, nausea, vomiting and abdominal pain. Symptoms may include headaches, blurred vision, fatigue, drowsiness and nervous system depression. CHRONIC: Repeated or prolonged exposure may cause skin rash and irritation of mucous membranes. Repeated ingestion may cause central nervous system deer ion, irritability and headache. Medical Conditions Aggravated by Exposure: Persons suffering from depression: alcoholism: neurological or psychological disorders may be more susceptible to the effects of the substance_ NFPA Rating: Health = 2: Flammability = 0: Instability = 0 11FPA Rating: Health = 2: Flammability = 0: Instability = 0 (Rating is for dry material, no information on blended solution).

Inhalation i. Immediately remove the victim to clean air. Call 911, inform the emergency dispatcher of a hydrofluoric acid exposure and request emergency transport. ii. Ensure emergency responders and treating physicians are aware of the nature of the chemical exposure. Provide a copy of the MSDS to emergency responders and request transport to Sparrow Hospital NOT Xxxx Health Center. iii. Inhalation of hydrofluoric acid fumes may cause swelling in the respiratory tract up to 24 hours after exposure. Persons who have inhaled hydrofluoric acid vapors must be transported to the hospital immediately. a. Container (tube) of 2.5% calcium gluconate gel. This gel is available from several suppliers. The gel must be inspected at least monthly to ensure that it is available and has not reached the expiration date. lf the gel has exceeded its shelf life or has been opened (i.e. used), a new tube must be purchased and the old container discarded. b. Two pairs of Neoprene or Nitrile gloves. c. Chemical safety goggles. d. Copy of these procedures and MSDS to provide to emergency response personnel. e. Easy-to-read emergency assistance instructions in language(s) pertinent to colleagues providing first aid to victim. The HF Exposure Kit in this laboratory can be found here:

Inhalation. The Contractor shall not use solvent products that when inhaled causes headaches, nausea, vomiting and dizziness from contact with the solvents; and,

Inhalation. Silicosis Respirable crystalline silica (quartz) can cause silicosis, a fibrosis (scarring) of the lungs. Silicosis may be progressive; it may lead to disability and death.

Inhalation. Personnel affected by methacrylic acid vapors must be moved at once to an uncontaminated atmosphere. another trained emergency health professional as soon as possible and transport to a suitable clinic or hospital. If breathing is difficult, trained personnel should administer oxygen.

Inhalation. This product does not produce any harmful fumes. --------------------------------------------------------------------------------------------------------------------- FIRE HAZARDS: NON-FLAMMABLE

Inhalation. Immediately move to fresh air. If not breathing give artificial respiration or, if breathing is difficult, give oxygen and notify medical personnel and supervisor.